GNTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Gentex Corp (GNTX) is not a strong buy for a beginner investor with a long-term strategy at this time. While the company shows stable financial growth and offers a dividend yield appealing to income-seeking investors, the technical indicators suggest a bearish trend, and insider selling activity raises concerns. Additionally, analysts have recently lowered price targets, reflecting cautious sentiment. It is advisable to hold off on investing until stronger bullish signals emerge.
The technical indicators show a bearish trend. The MACD histogram is negative and expanding downward, RSI is neutral at 39.859, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 24.177, with key support at 23.47 and resistance at 24.884.
Revenue increased by 18.97% YoY in Q4 2025, showing strong top-line growth.
Stable dividend payout of $0.12 per share with a forward yield of 2.04%, appealing to income investors.
Revenue target of $2.6 billion to $2.7 billion for 2026, focusing on product innovation.
Insider selling has increased significantly by 2411.11% over the last month, which could indicate lack of confidence in the stock's near-term performance.
Analysts have lowered price targets, reflecting cautious sentiment.
Technical indicators suggest a bearish trend, with the stock trading below key moving averages.
In Q4 2025, Gentex reported strong financial growth: Revenue increased by 18.97% YoY to $644.4 million, Net Income increased by 7.50% YoY to $92.96 million, EPS rose by 10.26% YoY to $0.43, and Gross Margin improved by 7.07% YoY to 34.84%.
Analysts have recently lowered price targets for Gentex: JPMorgan reduced the target to $28 from $29, Baird to $25 from $26, B. Riley to $28 from $32 (but maintains a Buy rating), and UBS to $25 from $26. The consensus sentiment is neutral, with cautious optimism from B. Riley citing long-term growth potential.
